Commentary: prognostication of chronic hepatitis B--are Fibrotest and Fibroscan the final answers?

Sun J; Liang X; Wong VW

doi:10.1111/apt.12326

Commentary: prognostication of chronic hepatitis B--are Fibrotest and Fibroscan the final answers?

MeSH — NLM indexing Elasticity Imaging Techniques Female Hepatitis B, Chronic / mortality Humans Liver / pathology Liver Cirrhosis / diagnosis Male

Acciones del personal

Descargar PDF

Los archivos son para uso autorizado únicamente en los canales asociados de BioPredictive.

Fibrotest Actitest Comment Independent Group

Autores (3)

Sun J — Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Guangzhou, China. doctorsunjian@qq.com
Liang X
Wong VW

Cita

Sun J, Liang X, Wong VW. Commentary: prognostication of chronic hepatitis B--are Fibrotest and Fibroscan the final answers?. Aliment Pharmacol Ther. 2013;37(11):1113. doi:10.1111/apt.12326.

Identificadores

DOI: 10.1111/apt.12326
PMID: 23656419

Pruebas

Enfermedades hepáticas

Lesiones hepáticas

Comparaciones

Temas

Carrito

Su carrito está vacío.

Explore las publicaciones y use Añadir al carrito en cualquier página de detalle para crear un archivo ZIP que pueda enviar a los clientes.

Explorar las publicaciones

Commentary: prognostication of chronic hepatitis B--are Fibrotest and Fibroscan the final answers?

Más sobre el mismo tema

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.